Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of imatinib and derivative thereof and analgesic in combined medication or compound preparation in treatment of pain

A derivative and analgesic technology, applied in pharmaceutical formulations, drug combinations, medical preparations containing active ingredients, etc. It can solve problems such as weak effect, and achieve the effect of solving clinical pain treatment problems, preventing serious side effects, and expanding clinical indications.

Pending Publication Date: 2021-03-30
安徽安迪克莱斯医药有限责任公司
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Non-steroidal anti-inflammatory analgesics, represented by aspirin, have analgesic effects mainly in the periphery, and the central analgesic effect is weak, mainly for pain caused by tissue damage or inflammation, by inhibiting the cyclooxygenase in the peripheral lesion (COX), which reduces the synthesis of PGS and relieves pain, has only a moderate analgesic effect, and has a good analgesic effect, but it is not effective for severe pain such as acute sharp pain, sharp pain caused by severe trauma, and smooth muscle colic
[0005] Other analgesics mainly act on receptors other than opioid receptors, such as NMDA receptors, NK1 receptors, purine and pyrimidine receptors, cannabinoid receptors and other drugs, and their analgesic effects are not strong, such as rotundine It has a good effect on chronic persistent dull pain, and its analgesic effect is weaker than that of meperidine, but stronger than that of antipyretic, analgesic and anti-inflammation drugs; gaurine can be used as an alternative drug for mild to moderate pain, but none of them can meet the current requirements. Treatment needs for severe pain
[0006] However, severe pain such as cancer pain, burns, knife wounds, etc. is caused by multiple factors, and the mechanism of pain is complicated. Only the use of peripheral analgesics cannot prevent severe pain, and central analgesia must be used.
Opioid analgesics such as morphine have powerful analgesic effects and are effective for all kinds of pain. They are in an irreplaceable position in clinical practice, but their side effects such as addiction and tolerance greatly limit their application.
At present, it is necessary to transform a single compound to solve the problem of having a strong analgesic effect while preventing serious side effects such as addiction and tolerance. Indeed, no good drug or compound has been found, and there is no drug or compound that can eliminate opioids in clinical practice. Better approaches to addiction and tolerance and treatments to reduce or delay the onset of drug addiction and tolerance, which can be difficult to treat in severe pain
On the other hand, although opioids have strong analgesic effects, their severe side effects such as addiction and tolerance also severely limit the scope of indications for the powerful analgesic effects of opioids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of imatinib and derivative thereof and analgesic in combined medication or compound preparation in treatment of pain
  • Application of imatinib and derivative thereof and analgesic in combined medication or compound preparation in treatment of pain
  • Application of imatinib and derivative thereof and analgesic in combined medication or compound preparation in treatment of pain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Embodiment 1: The effect of imatinib mesylate and morphine dose ratio on the formation of rat morphine addiction and its molecular mechanism Effects of Addiction Formation

[0046] 1. Materials

[0047] Drugs: morphine (Morphine, Qinghai Pharmaceutical Factory), imatinib mesylate (Selleck Chemicals).

[0048] Experimental animals: SPF grade SD male rats, weighing 180-220g. Provided by Hunan Slake Jingda Experimental Animal Experiment Co., Ltd., the animal certificate number is NO.43004700040706, and the production license number is SCXK (Xiang) 2016-0002. Rat feed was purchased from the Experimental Animal Center of Wuhan University.

[0049] Experimental instrument: conditional position preference instrument (developed by Institute of Materia Medica, Chinese Academy of Medical Sciences): the experiment adopts computer automatic control. The apparatus is a conditioned place preference chamber consisting of three chambers: two side chambers and a middle chamber. The...

Embodiment 2

[0065] Example 2: Influence of the dose-matching effect of imatinib mesylate and morphine on the formation of addiction to morphine during analgesia

[0066] It can be seen from Example 1 that imatinib and its derivative imatinib mesylate inhibit the formation of morphine addiction in rats by inhibiting the phosphorylation activity of c-kit in the nucleus accumbens region, and opioids such as morphine are clinically Commonly used analgesic drugs in the world, the dosage ratio of the two is greater than or equal to 2:1, which can prevent and treat the side effects of morphine addiction. In this embodiment, imatinib mesylate and morphine are selected as the analgesic for acute visceral pain caused by acetic acid in mice Drugs, by establishing an experimental model of acetic acid-induced pain in mice and a conditioned place preference experimental model, to explore the effect of the dose ratio effect of imatinib mesylate and morphine on the formation of morphine addiction in mice ...

Embodiment 3

[0077] Example 3: Effect of imatinib mesylate on morphine tolerance in rats

[0078] From the results of Examples 1 and 2, it can be seen that the imatinib mesylate and morphine composition greater than or equal to a dose ratio of 2:1 can obviously prevent the formation of morphine addiction in rats or mice, and the present embodiment selects mesylate Imatinib mesylate and morphine are used as analgesic drugs for central pain in rats. Through the establishment of morphine tolerance and hot plate pain models in rats, the effects of combined administration and compound administration of imatinib mesylate and morphine on morphine tolerance were investigated. influenced by.

[0079] 1. Materials

[0080] Drugs: morphine (Qinghai Pharmaceutical Factory); imatinib mesylate (Selleck Chemicals).

[0081] Experimental animals: SPF grade SD female rats, weighing 180-220g. Provided by the Experimental Animal Center of China Three Gorges University, the animal certificate number is NO....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of imatinib and a derivative thereof and an analgesic drug in combined medication or compound preparation in treatment of pain, and belongs to the technical field of medicines. The medicine provided by the invention is a composition containing imatinib and a derivative thereof and an analgesic in a dosage ratio of more than or equal to 2:1, and can be used for preparing a medicine for treating pain and a medicine for preventing analgesic tolerance and addiction side effects; and when the composition is used for preparing the medicine, the dosage of the imatinib and the derivative thereof is 100-400mg / day, and the imatinib and the derivative thereof and the analgesic medicine can be simultaneously, separately or sequentially applied. The imatinib and the derivative thereof and the analgesic are combined or compounded according to the dosage ratio of more than or equal to 2:1 for medication, so that the analgesic effect of the analgesic can be effectively exerted, meanwhile, the serious side effects of opioid drugs can be effectively prevented, and the analgesic effect of the opioid drugs is not influenced; and the clinical indications of the addictive analgesic analgesic are further expanded.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to the application of imatinib and its derivatives in combination with opioid drugs or prepared as a compound preparation in pain treatment. Background technique [0002] At present, the commonly used analgesics in clinical practice are mainly opioid analgesics represented by morphine, non-steroidal anti-inflammatory analgesics represented by aspirin, and other analgesics. Act on the central or peripheral nervous system, peripheral tissue inflammation, etc. to selectively reduce and eliminate various pains to achieve analgesic effect. [0003] Opioid analgesics exert analgesic effect mainly by stimulating opioid receptors. Opioid receptors are distributed in a high density in the medial thalamus, spinal cord glial area, and ventricle, and are related to the afferent pain stimulus, the integration and perception of pain signals, Including μ, δ, and κ receptors, all of wh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/506A61K45/06A61P25/04A61P25/36A61K31/485
CPCA61K31/485A61K31/506A61K45/06A61P25/04A61P25/36A61K2300/00
Inventor 李艳琴朱世敏阮佳伟张新宇陈明珠
Owner 安徽安迪克莱斯医药有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products